You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 812 Reprograming of tumor-associated myeloid cells by TLR9-targeted STAT3 antisense oligonucleotides sensitizes malignant glioma to PD1-specific immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
812 Reprograming of tumor-associated myeloid cells by TLR9-targeted STAT3 antisense oligonucleotides sensitizes malignant glioma to PD1-specific immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023164024
Dec 20235405
Jan 20244302
Feb 20243601
Mar 20242400
Apr 20242004
May 20241802
Jun 20241000
Jul 20243401
Aug 20241601
Sep 20243202
Oct 202426010
Nov 20244206
Dec 20243408
Jan 20252005
Feb 202528010
Mar 2025009
Apr 2025005
May 2025005
Jun 2025003
Total6010103